Stay informed with the latest in insolvency news and industry updates. We can keep you up to date with insolvency and finance information from around the world.
Company will explore strategic alternatives for its immuno-oncology programsCompany will align its resources to focus on HEPLISAV-B commercializationEddie Gray, CEO,